GeneOne Life Science, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 231.76 million compared to KRW 149.88 million a year ago. Net loss was KRW 13,212.15 million compared to KRW 4,621.83 million a year ago.

Basic loss per share from continuing operations was KRW 170 compared to KRW 60 a year ago. Diluted loss per share from continuing operations was KRW 170 compared to KRW 60 a year ago. Basic loss per share was KRW 170 compared to KRW 60 a year ago.